Stockreport

Pasithea Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference [Yahoo! Finance]

Pasithea Therapeutics Corp.  (KTTA) 
PDF clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other cance [Read more]